HEADER TRANSCRIPTION/DNA 28-NOV-13 4CH1 TITLE RRM DOMAIN FROM C. ELEGANS SUP-12 BOUND TO GGTGTGC DNA COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN SUP-12, ISOFORM B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RRM DOMAIN, RESIDUES 28-121; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: GGTGTGC; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: SUP-12 BINDING MOTIF; COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: THE HEPTAMER SEQUENCE IS DERIVED FROM THE INTRON COMPND 12 BETWEEN EXONS 4 AND 5B FROM THE C. ELEGANS EGL-15 GENE. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CAENORHABDITIS ELEGANS; SOURCE 3 ORGANISM_TAXID: 6239; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VARIANT: PLYSY; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-HIS1A; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: CAENORHABDITIS ELEGANS; SOURCE 13 ORGANISM_TAXID: 6239 KEYWDS TRANSCRIPTION-DNA COMPLEX, MUSCLE, DEVELOPMENT EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR S.AMRANE,C.D.MACKERETH REVDAT 6 15-MAY-24 4CH1 1 REMARK REVDAT 5 24-JAN-18 4CH1 1 REMARK REVDAT 4 27-APR-16 4CH1 1 ATOM TER MASTER REVDAT 3 17-SEP-14 4CH1 1 JRNL REVDAT 2 10-SEP-14 4CH1 1 TITLE REVDAT 1 03-SEP-14 4CH1 0 JRNL AUTH S.AMRANE,K.REBORA,I.ZNIBER,D.DUPUY,C.D.MACKERETH JRNL TITL BACKBONE-INDEPENDENT NUCLEIC ACID BINDING BY SPLICING FACTOR JRNL TITL 2 SUP-12 REVEALS KEY ASPECTS OF MOLECULAR RECOGNITION JRNL REF NAT.COMMUN. V. 5 4595 2014 JRNL REFN ESSN 2041-1723 JRNL PMID 25183497 JRNL DOI 10.1038/NCOMMS5595 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,READ, RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4CH1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-NOV-13. REMARK 100 THE DEPOSITION ID IS D_1290059104. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.0; 298.0; 298.0; 298.0; REMARK 210 298.0 REMARK 210 PH : 6.5; 6.5; 6.5; 6.5; 6.5 REMARK 210 IONIC STRENGTH : 300; 300; 300; 300; 300 REMARK 210 PRESSURE : 1.0 ATM; 1.0 ATM; 1.0 ATM; 1.0 REMARK 210 ATM; 1.0 ATM REMARK 210 SAMPLE CONTENTS : 10% WATER/90% D2O; 100% D2O; REMARK 210 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 15N-NOESY; 13C-NOESY; DOUBLE- REMARK 210 FILTERED 1H; 1H- NOESY; 1H-TOCSY; REMARK 210 1H-NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, SPARKY REMARK 210 METHOD USED : ARIA1.2 REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST ENERGY AND NO VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 6 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED BY USING MULTI- DIMENSIONAL REMARK 210 NMR SPECTRSOCOPY WITH 15N-, 13C,15N-, OR 2H- LABELED SUP-12 IN REMARK 210 COMPLEX WITH A NATURAL ABUNDANCE GGTGTGC DNA LIGAND, OR A LIGAND REMARK 210 WITH SITE-SPECIFIC 13C,15N- LABELING. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 62 HZ1 LYS A 84 1.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 MET A 27 -80.46 -122.28 REMARK 500 1 ARG A 117 -24.56 74.18 REMARK 500 2 PRO A 96 2.55 -69.72 REMARK 500 3 PRO A 116 31.98 -74.45 REMARK 500 3 VAL A 120 -54.39 74.88 REMARK 500 4 ASP A 60 123.17 72.82 REMARK 500 5 ALA A 26 -50.24 73.44 REMARK 500 5 MET A 27 165.81 81.00 REMARK 500 5 PRO A 96 0.90 -69.72 REMARK 500 5 PRO A 116 -147.64 -64.40 REMARK 500 5 THR A 118 -47.52 -155.70 REMARK 500 6 ALA A 26 -82.03 -119.07 REMARK 500 6 PRO A 116 35.61 -83.29 REMARK 500 6 ARG A 117 67.90 -111.22 REMARK 500 6 THR A 118 174.58 169.28 REMARK 500 7 PRO A 96 3.62 -69.55 REMARK 500 7 ARG A 117 -75.31 57.81 REMARK 500 8 ARG A 117 89.20 57.72 REMARK 500 8 THR A 118 -80.41 -84.24 REMARK 500 8 ASN A 119 116.37 174.56 REMARK 500 8 VAL A 120 -74.32 -76.97 REMARK 500 9 VAL A 120 144.15 72.99 REMARK 500 10 PRO A 116 39.52 -75.74 REMARK 500 10 THR A 118 100.98 70.77 REMARK 500 10 VAL A 120 114.37 72.95 REMARK 500 11 ALA A 26 78.39 66.57 REMARK 500 11 PRO A 96 7.25 -68.90 REMARK 500 11 ASN A 119 95.69 67.91 REMARK 500 12 SER A 29 35.42 -79.52 REMARK 500 12 ARG A 117 119.71 -160.22 REMARK 500 12 ASN A 119 -71.41 -58.95 REMARK 500 12 VAL A 120 -63.66 68.52 REMARK 500 13 ALA A 26 104.31 -163.45 REMARK 500 14 MET A 27 92.61 69.54 REMARK 500 14 PRO A 116 29.38 -79.91 REMARK 500 14 ASN A 119 -54.77 -139.48 REMARK 500 15 ALA A 26 -88.08 67.09 REMARK 500 15 MET A 27 76.82 -102.65 REMARK 500 15 SER A 29 89.40 60.52 REMARK 500 15 ARG A 117 82.28 77.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CH0 RELATED DB: PDB REMARK 900 RRM DOMAIN FROM C. ELEGANS SUP-12 REMARK 900 RELATED ID: 19653 RELATED DB: BMRB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SAMPLE CONTAINS AN ADDITIONAL GLY-ALA-MET- AT THE N- REMARK 999 TERMINUS FOLLOWING CLEAVAGE BY TEV PROTEASE DBREF 4CH1 A 28 121 UNP H2L051 H2L051_CAEEL 28 121 DBREF 4CH1 B 1 7 PDB 4CH1 4CH1 1 7 SEQADV 4CH1 GLY A 25 UNP H2L051 EXPRESSION TAG SEQADV 4CH1 ALA A 26 UNP H2L051 EXPRESSION TAG SEQADV 4CH1 MET A 27 UNP H2L051 EXPRESSION TAG SEQRES 1 A 97 GLY ALA MET GLY SER ARG ASP THR MET PHE THR LYS ILE SEQRES 2 A 97 PHE VAL GLY GLY LEU PRO TYR HIS THR SER ASP LYS THR SEQRES 3 A 97 LEU HIS GLU TYR PHE GLU GLN PHE GLY ASP ILE GLU GLU SEQRES 4 A 97 ALA VAL VAL ILE THR ASP ARG ASN THR GLN LYS SER ARG SEQRES 5 A 97 GLY TYR GLY PHE VAL THR MET LYS ASP ARG ALA SER ALA SEQRES 6 A 97 GLU ARG ALA CYS LYS ASP PRO ASN PRO ILE ILE ASP GLY SEQRES 7 A 97 ARG LYS ALA ASN VAL ASN LEU ALA TYR LEU GLY ALA LYS SEQRES 8 A 97 PRO ARG THR ASN VAL GLN SEQRES 1 B 7 DG DG DT DG DT DG DC HELIX 1 1 SER A 47 GLU A 56 1 10 HELIX 2 2 GLN A 57 GLY A 59 5 3 HELIX 3 3 ASP A 85 ASP A 95 1 11 HELIX 4 4 TYR A 111 GLY A 113 5 3 SHEET 1 AA 4 ILE A 61 THR A 68 0 SHEET 2 AA 4 SER A 75 MET A 83 -1 N ARG A 76 O ILE A 67 SHEET 3 AA 4 LYS A 36 GLY A 40 -1 O ILE A 37 N VAL A 81 SHEET 4 AA 4 ASN A 106 LEU A 109 -1 O ASN A 106 N GLY A 40 SHEET 1 AB 2 ILE A 99 ILE A 100 0 SHEET 2 AB 2 ARG A 103 LYS A 104 -1 O ARG A 103 N ILE A 100 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1